Michael KASSIOU,William JORGENSEN,Eryn WERRY,Tristan REEKIE,Michael BOWEN,Iain MCGREGOR
申请号：
US16439570
公开号：
US20200000823A1
申请日:
2019.06.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein are compounds according to Formula I； a pharmaceutical composition including, consisting essentially of, or consisting of: a pharmaceutically acceptable compound of Formula I and a pharmaceutically acceptable carrier, diluent, or excipient； the use of compounds of Formula I in the preparation of a medicament； and a method including administering a pharmaceutical compositions comprising the compound of Formula I to a patient. The compounds, compositions, use, and methods are directed to the treatment of neurological, psychiatric disorders which are characterised by a fundamental disruption of social behaviour, and substance use disorders.
